[Beijing Direct News Network May 7th] (Freida)At present, the spread of the global epidemic and the downward pressure of the economy are superimposed, and a turning point appears in the new round of industrial restructuring, especially in the health industry. The epidemic accelerated the development of Internet plus medical health. The changes in terminal medical treatment and drug purchase scenarios are giving birth to the restructuring of the pharmaceutical industry and gradually entering the era of health data.

At the same time of doing a good job in the prevention and control of the normal epidemic situation, furida in Shandong Province has deepened the market-oriented reform, accelerated the pace of innovation, transformation and upgrading, expanded the domestic and international markets, explored new opportunities, and fostered new growth points. Jia Qingwen, general manager of Shandong furida Pharmaceutical Group Co., Ltd., said in an exclusive interview with the reporter of China Economic Times recently that in the future, furida will seize the opportunity of capital operation and the implementation of major projects to convert new and old kinetic energy, focus on high-end generic drugs, modern Chinese medicine, innovative drugs and biotechnology cosmetics, and vigorously implement the three strategies of "innovation driven, talent led and brand driven", Strive to realize the development of light assets, intelligence, capitalization, cooperation and technology.

In the face of the sudden outbreak, Freida actively implemented the work deployment of the Party Central Committee and the governments at all levels. While doing a good job in epidemic prevention and control, Freida returned to work in a timely, safe and orderly manner. "Up to now, Freida's return to work rate has reached 100%." Jia Qingwen said.

Since the outbreak of the epidemic, the pharmaceutical and cosmetics sectors of Freida's main business have been impacted to varying degrees. Jia Qingwen told reporters that Freida always pays attention to the development of the epidemic situation, the cosmetics sector responds to the needs of anti epidemic quickly, overcomes various practical difficulties in the early stage of the epidemic situation, quickly organizes R & D personnel, works overtime, conducts R & D and production license application of disinfection and sterilization products, and successfully goes on the market.

During the epidemic period, Freida implemented the responsibility and responsibility of state-owned enterprises, donated 20000 boxes of recommended drugs for the war of 500000 yuan in total - xiaoerjiegan granules at the first time, and organized the group to actively donate to help Wuhan and the whole country fight against the epidemic.

Whether it's drug donation, charity donation, employee training, online marketing, Freida has achieved the two goals of epidemic prevention and control and return to work and production, and tried its best to minimize the impact of the epidemic.

"Online sales in the cosmetics sector have maintained a high growth; sales losses in the pharmaceutical sector can be digested through future efforts. We propose to stabilize in the second quarter. In the second half of the year, we hope to promote more marketing model innovation through the Internet platform, and strive to make up for the lost time and sales vacancy in the first quarter." Jia Qingwen said.

In response to the impact of the epidemic, Freida also made fine adjustments in the direction and focus of product research and development. "Now we pay more attention to the R & D and investment of health killing products, because these products are not as high as the drug threshold, so we can use the advantages of our original online channels to cultivate new profit growth points through the rapid distribution of these products." Jia Qingwen said, including our industrial park, which was originally called biomedical health industrial park, has now been adjusted to health care products industrial park.

At the same time, Freida has more clearly defined the strategic positioning and development direction of the medical and health business, focused on drugs and cosmetics, and focused on building China's leading brand of orthopedic drugs and hyaluronic acid high-end cosmetics.

Jia Qingwen said that Freida will pool its wisdom, accelerate innovation, transformation and upgrading, continue to deepen market-oriented reform, make every effort to carry out mechanism innovation, model innovation, scientific and technological innovation, management innovation and technological innovation, and open up a new situation of in-depth development in many health fields, including biomedicine, high-end cosmetics and biological raw materials.